drugset / Trial / NCT00888628

Study of Islet Transplantation in Type 1 Diabetic Kidney Transplant Recipients

NCT00888628

NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to learn if islet transplantation is an effective treatment for Type 1 diabetes in people who have had a kidney transplant. The primary objectives of the study are: \- To set up islet transplantation in patients who have had a kidney transplant and who are using an immunosuppressive regimen that works The Secondary objective of the study is: * To find out if successful islet transplantation leads to improved metabolic control and reduced renal complication from diabetes

Timeline

Start
2009-05
Primary completion
2014-08
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Purified Pancreatic Islets Cell therapy
Background Etanercept Protein / enzyme biologic